Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting

Replication-defective adenovirus (ADV) and poxvirus vectors have shown potential as vaccines for pathogens such as Ebola or human immunodeficiency virus in nonhuman primates, but prior immunity to the viral vector in humans may limit their clinical efficacy. To overcome this limitation, the effect o...

Full description

Bibliographic Details

Published in:	J Virol
Main Authors:	Yang, Zhi-yong, Wyatt, Linda S., Kong, Wing-pui, Moodie, Zoe, Moss, Bernard, Nabel, Gary J.
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 2003
Subjects:	Vaccines and Antiviral Agents
Online Access:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140625/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12477888/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.1.799-803.2003
Tags:	Add Tag No Tags, Be the first to tag this record!